Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

The Investment Case For AstraZeneca plc

| Tony Reading

AstraZeneca plc (LON:AZN) is a biotech play that pays a dividend.

Read more »

Company Comment

There’s A Patent Cliff But AstraZeneca plc Has A Jetpack

| Mark Stones

How scientific research can put AstraZeneca plc (LON: AZN) back on track for growth.

Read more »

Investing Articles

3 FTSE 100 Shares Hitting New Highs: AstraZeneca plc, Associated British Foods plc and Admiral Group plc

| Alan Oscroft

AstraZeneca plc (LON: AZN), Associated British Foods plc (LON: ABF) and Admiral Group plc (LON: ADM) all spike upwards.

Read more »

Investing Articles

3 FTSE 100 Shares Hitting New Highs: Aviva plc, Vodafone Group plc and AstraZeneca plc

| Alan Oscroft

Aviva plc (LON: AV), Vodafone Group plc (LON: VOD) and AstraZeneca plc (LON: AZN) are flying even higher.

Read more »

Investing Videos

AstraZeneca Plc Confident Over Revenues Until 2017

| Owain Bennallack

VIDEO: One Fool puts AstraZeneca plc (LON:AZN) under the spotlight, and compares it with GlaxoSmithKline plc (LON:GSK).

Read more »

Investing Articles

AstraZeneca plc Upbeat On Revenue Recovery

| Maynard Paton

AstraZeneca plc (LON: AZN) says a return to sales growth should come earlier than expected.

Read more »

Investing Articles

Why GlaxoSmithKline plc, AstraZeneca plc and Marks and Spencer Group Plc Should Beat The FTSE 100 Today

| Alan Oscroft

GlaxoSmithKline plc (LON: GSK), AstraZeneca plc (LON: AZN) and Marks and Spencer Group Plc (LON: MKS) respond well to news.

Read more »

Investing Articles

The Hidden Nasty In AstraZeneca plc’s Latest Results

| Roland Head

AstraZeneca plc (LON:AZN) is a fine company, but Roland Head has noticed a disturbing trend in the firm's clinical trials…

Read more »

Investing Articles

Why AstraZeneca plc Should Be A Winner Next Year

| Alan Oscroft

AstraZeneca plc (LON:AZN) is heading back to strength in 2014.

Read more »

Investing Articles

How Will AstraZeneca Plc Fare In 2014?

| Kevin Godbold

Should I invest in AstraZeneca plc (LON: AZN) for 2014 and beyond?

Read more »

Investing Articles

3 FTSE Shares Hitting New Highs: ARM Holdings plc, AstraZeneca plc and WPP PLC

| Alan Oscroft

ARM Holdings plc (LON: ARM), AstraZeneca plc (LON: AZN) and WPP PLC (LON: WPP) climb ever higher.

Read more »

Investing Articles

Is AstraZeneca plc Set For Electrifying Earnings Growth In 2014?

| Royston Wild

Royston Wild looks at AstraZeneca plc's (LON: AZN) growth prospects for the new year.

Read more »